PharmiWeb.com - Global Pharma News & Resources
28-Jun-2019

Clinical Nutrition Market Size is Anticipated to Surpass USD 87 Billion up to 2026

The Global Clinical Nutrition Market Size is expected to reach USD 87 Billion by 2026 and growing CAGR around 8.5 % during the forecast period.

According to the report named ldquo;Clinical nutrition Market- Global Industry Analysis, Growth, Share, Size, Trends and Forecast, 2018-2026rdquo;, growing number of people suffering from chronic diseases such as diabetes and cancer, growing demand for better and accurate diagnostic procedures,growth in the obese population, rising awareness towards the health related concerns, enhanced healthcare system, various research and development activities, and initiatives taken by favourable governments are some of the key factors that are fuelling the clinical nutrition market growth across the globe. North America is anticipated to witness the highest growth rate over the forecast period owing to the availability of wide range of various better and accurate disease diagnostic methods, early adoption of various advanced diagnostic methods and ongoing technological advancements in the healthcare industry. Awareness programs conducted by various organizations are also playing the major role in the growth of regional clinical nutrition market.

Free Download Sample Report Pages For Better Understanding@ https://www.acumenresearchandconsulting.com/request-sample/1178

Rising Occurrences of Chronic Diseases and Ease of Availability of Various Clinical Nutrition Solutions to Drive the Global Clinical nutrition Market Growth

Rising occurrences of various chronic diseases such as diabetes, cancer and various initiatives taken by favourable governments are some of the fundamental factors driving the global clinical nutrition market growth. Growing prevalence of chronic diseases and lack of nutrients are anticipated to increase the growth of clinical nutrition prescriptions and also create immense opportunities for the global clinical nutrition market over the forecast period. The growing demand for improved and accurate diagnostic procedures due to the growth in prevalence of the various diseases is projected to boost the adoption of clinical nutrition methods throughout the forecast period. Several initiatives in order to decrease the cost required to cure these diseases is also anticipated to supplement the overalls market growth during the forecast period. Ever increasing obese population owing to the unhealthy nutritional habits and lack of physical activities are expected to further spur the overall market growth. A large number of aged people suffer from various digestive and appetite problems, and this needs nutrients supply through enteral or parenteral route, thereby, boosting the market growth. Malnourishment is the major issue generally occurred in pre mature babies. Rising number of pre-mature babies across the globe is driving the overall clinical nutrition market growth. Growing awareness programs and camps regarding various chronic diseases organized by domestic governments and increasing occurrences of enfeebling diseases coupled with the growing aged population base are some of the other factors driving the overall clinical nutrition market growth.

Browse All official Market Asia Pacific to Grow at Highest Rate inClinical nutrition Market

Geographically, the global clinical nutrition market has been divided into North America, Europe, Asia Pacific, Latin America and Middle East and Africa. North America is anticipated to contribute the highest revenue share and grow at highest CAGR during the forecast period owing to the availability of wide range of various better and accurate disease diagnostic methods, early adoption of various advanced diagnostic methods and ongoing technological advancements in the healthcare industry. Awareness programs conducted by various organizations are also playing the major role in the growth of regional clinical nutrition market. Growing inclination towards more advanced disease diagnostics methods and rapid growth in the healthcare industry is supplementing the regional market growth. Asia Pacific is also expected to show substantial growth over the forecast period due to presence of large number of patient base, growth in the obese population. Infrastructural development and early and growing disposable income in the emerging countries are some of the key factors fueling the regional market growth.

To Purchase this Premium Report at https://www.acumenresearchandconsulting.com/buy-now/0/1178

Market Players

The clinical nutrition market is consolidated with large number of manufacturers. The company profiling of key players in the market includes major business strategies, company overview and revenues. The key players of the market are Nestle Nutrition, Lonza Ltd, Hospira Inc., Mead Johnson amp; Company, Kendall, Gentiva Health Services Inc., Abbott Laboratories Inc., H. J. Heinz Company, Ajinomoto Co. Inc., Baxter International Inc., American Home Patient Inc., Hero Nutritionals Inc., B. Braun Melsungen AG, and Fresenius Kabi.

TABLE OF CONTENT

CHAPTER 1. INDUSTRY OVERVIEW

1.1. Definition and Scope
1.1.1. Definition of Clinical Nutrition
1.1.2. Market Segmentation
1.1.3. List of Abbreviations
1.2. Summary
1.2.1. Market Snapshot
1.2.2. Clinical Nutrition Market By Product
1.2.2.1. Global Clinical Nutrition Market Revenue and Growth Rate Comparison By Product (2015-2026)
1.2.2.2. Global Clinical Nutrition Market Revenue Share By Product in 2017
1.2.2.3. Infant Nutrition
1.2.2.4. Enteral Nutrition
1.2.2.5. Parenteral Nutrition
1.2.2.6. Others
1.2.3. Clinical Nutrition Market By Consumer
1.2.3.1. Global Clinical Nutrition Market Revenue and Growth Rate Comparison By Consumer (2015-2026)
1.2.3.2. Global Clinical Nutrition Market Revenue Share By Consumer in 2017
1.2.3.3. Child
1.2.3.4. Adult
1.2.3.5. Others
1.2.4. Clinical Nutrition Market by Geography
1.2.4.1. Global Clinical Nutrition Market Revenue and Growth Rate Comparison by Geography (2015-2026)
1.2.4.2. North America Clinical Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.4.3. Europe Clinical Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.4.4. Asia-Pacific Clinical Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.4.5. Latin America Clinical Nutrition Market Revenue and Growth Rate (2015-2026)
1.2.4.6. Middle East and Africa (MEA) Clinical Nutrition Market Revenue and Growth Rate (2015-2026)

CHAPTER 2. MARKET DYNAMICS AND COMPETITION ANALYSIS

2.1. Market Drivers
2.2. Restraints and Challenges
2.3. Growth Opportunities
2.4. Porterrsquo;s Five Forces Analysis
2.4.1. Bargaining Power of Suppliers
2.4.2. Bargaining Power of Buyers
2.4.3. Threat of Substitute
2.4.4. Threat of New Entrants
2.4.5. Degree of Competition
2.5. Value Chain Analysis
2.6. Cost Structure Analysis
2.6.1. Raw Material and Suppliers
2.6.2. Manufacturing Process Analysis
2.7. Regulatory Compliance
2.8. Competitive Landscape, 2017
2.8.1. Player Positioning Analysis
2.8.2. Key Strategies Adopted By Leading Players

CHAPTER 3. MANUFACTURING PLANTS ANALYSIS

3.1. Capacity and Commercial Production Date of Global Clinical Nutrition Major Manufacturers in 2017
3.2. Manufacturing Plants Distribution of Global Clinical Nutrition Major Manufacturers in 2017
3.3. Ramp;D Status and Technology Source of Global Clinical Nutrition Major Manufacturers in 2017
3.4. Raw Materials Sources Analysis of Global Clinical Nutrition Major Manufacturers in 2017

CHAPTER 4. CLINICAL NUTRITION MARKET BY PRODUCT

4.1. Global Clinical Nutrition Revenue By Product
4.2. Infant Nutrition
4.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.3. Enteral Nutrition
4.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.4. Parenteral Nutrition
4.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
4.5. Others
4.5.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
4.5.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 5. CLINICAL NUTRITION MARKET BY CONSUMER

5.1. Global Clinical Nutrition Revenue By Consumer
5.2. Child
5.2.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.2.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.3. Adult
5.3.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.3.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)
5.4. Others
5.4.1. Market Revenue and Growth Rate, 2015 - 2026 ($Million)
5.4.2. Market Revenue and Forecast, By Region, 2015 - 2026 ($Million)

CHAPTER 6. NORTH AMERICA CLINICAL NUTRITION MARKET BY COUNTRY

6.1. North America Clinical Nutrition Market Revenue and Growth Rate, 2015 - 2026 ($Million)
6.2. North America Clinical Nutrition Market Revenue Share Comparison, 2015 amp; 2026 (%)
6.3. U.S.
6.3.1. U.S. Clinical Nutrition Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.3.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
6.4. Canada
6.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.4.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
6.5. Mexico
6.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
6.5.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)

CHAPTER 7. EUROPE CLINICAL NUTRITION MARKET BY COUNTRY

7.1. Europe Clinical Nutrition Market Revenue and Growth Rate, 2015 - 2026 ($Million)
7.2. Europe Clinical Nutrition Market Revenue Share Comparison, 2015 amp; 2026 (%)
7.3. UK
7.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.3.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
7.4. Germany
7.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.4.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
7.5. France
7.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.5.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
7.6. Spain
7.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.6.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
7.7. Rest of Europe
7.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
7.7.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)

CHAPTER 8. ASIA-PACIFIC CLINICAL NUTRITION MARKET BY COUNTRY

8.1. Asia-Pacific Clinical Nutrition Market Revenue and Growth Rate, 2015 - 2026 ($Million)
8.2. Asia-Pacific Clinical Nutrition Market Revenue Share Comparison, 2015 amp; 2026 (%)
8.3. China
8.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.3.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
8.4. Japan
8.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.4.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
8.5. India
8.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.5.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
8.6. Australia
8.6.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.6.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
8.7. South Korea
8.7.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.7.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
8.8. Rest of Asia-Pacific
8.8.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
8.8.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)

CHAPTER 9. LATIN AMERICA CLINICAL NUTRITION MARKET BY COUNTRY

9.1. Latin America Clinical Nutrition Market Revenue and Growth Rate, 2015 - 2026 ($Million)
9.2. Latin America Clinical Nutrition Market Revenue Share Comparison, 2015 amp; 2026 (%)
9.3. Brazil
9.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.3.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
9.4. Argentina
9.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.4.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
9.5. Rest of Latin America
9.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
9.5.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)

CHAPTER 10. MIDDLE EAST CLINICAL NUTRITION MARKET BY COUNTRY

10.1. Middle East Clinical Nutrition Market Revenue and Growth Rate, 2015 - 2026 ($Million)
10.2. Middle East Clinical Nutrition Market Revenue Share Comparison, 2015 amp; 2026 (%)
10.3. Saudi Arabia
10.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.3.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
10.4. UAE
10.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.4.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
10.5. Rest of Middle East
10.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
10.5.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)

CHAPTER 11. AFRICA CLINICAL NUTRITION MARKET BY COUNTRY

11.1. Africa Clinical Nutrition Market Revenue and Growth Rate, 2015 - 2026 ($Million)
11.2. Africa Clinical Nutrition Market Revenue Share Comparison, 2015 amp; 2026 (%)
11.3. South Africa
11.3.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.3.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
11.4. Egypt
11.4.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.4.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)
11.5. Rest of Africa
11.5.1. Market Revenue and Forecast By Product, 2015 - 2026 ($Million)
11.5.2. Market Revenue and Forecast By Consumer, 2015 - 2026 ($Million)

CHAPTER 12. COMPANY PROFILE

12.1. Nestle Nutrition
12.1.1. Company Snapshot
12.1.2. Overview
12.1.3. Financial Overview
12.1.4. Product Portfolio
12.1.5. Key Developments
12.1.6. Strategies
12.2. Lonza Ltd
12.2.1. Company Snapshot
12.2.2. Overview
12.2.3. Financial Overview
12.2.4. Product Portfolio
12.2.5. Key Developments
12.2.6. Strategies
12.3. Hospira Inc.
12.3.1. Company Snapshot
12.3.2. Overview
12.3.3. Financial Overview
12.3.4. Product Portfolio
12.3.5. Key Developments
12.3.6. Strategies
12.4. Mead Johnson amp; Company
12.4.1. Company Snapshot
12.4.2. Overview
12.4.3. Financial Overview
12.4.4. Product Portfolio
12.4.5. Key Developments
12.4.6. Strategies
12.5. Kendall
12.5.1. Company Snapshot
12.5.2. Overview
12.5.3. Financial Overview
12.5.4. Product Portfolio
12.5.5. Key Developments
12.5.6. Strategies
12.6. Gentiva Health Services Inc.
12.6.1. Company Snapshot
12.6.2. Overview
12.6.3. Financial Overview
12.6.4. Product Portfolio
12.6.5. Key Developments
12.6.6. Strategies
12.7. Abbott Laboratories Inc.
12.7.1. Company Snapshot
12.7.2. Overview
12.7.3. Financial Overview
12.7.4. Product Portfolio
12.7.5. Key Developments
12.7.6. Strategies
12.8. H. J. Heinz Company
12.8.1. Company Snapshot
12.8.2. Overview
12.8.3. Financial Overview
12.8.4. Product Portfolio
12.8.5. Key Developments
12.8.6. Strategies
12.9. Ajinomoto Co. Inc.
12.9.1. Company Snapshot
12.9.2. Overview
12.9.3. Financial Overview
12.9.4. Product Portfolio
12.9.5. Key Developments
12.9.6. Strategies
12.10. Baxter International Inc.
12.10.1. Company Snapshot
12.10.2. Overview
12.10.3. Financial Overview
12.10.4. Product Portfolio
12.10.5. Key Developments
12.10.6. Strategies
12.11. American Home Patient Inc.
12.11.1. Company Snapshot
12.11.2. Overview
12.11.3. Financial Overview
12.11.4. Product Portfolio
12.11.5. Key Developments
12.11.6. Strategies
12.12. Hero Nutritionals Inc.
12.12.1. Company Snapshot
12.12.2. Overview
12.12.3. Financial Overview
12.12.4. Product Portfolio
12.12.5. Key Developments
12.12.6. Strategies
12.13. B. Braun Melsungen AG
12.13.1. Company Snapshot
12.13.2. Overview
12.13.3. Financial Overview
12.13.4. Product Portfolio
12.13.5. Key Developments
12.13.6. Strategies
12.14. Fresenius Kabi
12.14.1. Company Snapshot
12.14.2. Overview
12.14.3. Financial Overview
12.14.4. Product Portfolio
12.14.5. Key Developments
12.14.6. Strategies
12.15. Others
12.15.1. Company Snapshot
12.15.2. Overview
12.15.3. Financial Overview
12.15.4. Product Portfolio
12.15.5. Key Developments
12.15.6. Strategies

CHAPTER 13. RESEARCH APPROACH

13.1. Research Methodology
13.1.1. Initial Data Search
13.1.2. Secondary Research
13.1.3. Primary Research
13.2. Assumptions and Scope

Buy this Premium Research Report at https://www.acumenresearchandconsulting.com/buy-now/0/1178

The report is readily available and can be dispatched immediately after payment confirmation.

Would like to place an order or any question, please feel free to contact atsales@acumenresearchandconsulting.com| +1 407 915 4157

About Acumen Research and Consulting:

Acumen Research and Consulting (ARC) is a global provider of market intelligence and consulting services to information technology, investment, telecommunication, manufacturing, and consumer technology markets. ARC helps investment communities, IT professionals, and business executives to makefact baseddecisions on technology purchases and develop firm growth strategies to sustain market competition. With the team size of 100+ Analysts and collective industry experience of more than 200 years, Acumen Research and Consulting assures to deliver a combination of industry knowledge along with global and country level expertise.

Editor Details

Last Updated: 28-Jun-2019